Cohance Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company, for the quarter and nine-months ending December 31, 2025